Hyperfine has presented positive interim data from the ACTION PMR study, demonstrating that its magnetic resonance brain ...
Maria Sainz, Hyperfine, Inc. President and CEO, adds, “The ACTION PMR study shows that the Swoop system has the potential to activate a paradigm shift in stroke diagnosis and treatment all over ...
The decision comes after Hyperfine's Swoop® system, an AI-powered medical device, received initial FDA clearance in 2020, followed by nine subsequent software clearances. The company is also ...
Hyperfine, Inc. is a medical device development ... It also develops imaging of health conditions through its Swoop portable magnetic resonance. The company was founded by Jonathan M.
Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference Two presentations at ISC build on a growing ...
Hyperfine, Inc. (Nasdaq ... brain imaging system—the Swoop® system—today announced the presentation of two studies at the 2025 International Stroke Conference (ISC), which provide evidence ...